Who is sponsoring NCT03687710?

NCT03687710 is sponsored by Weill Medical College of Cornell University.

What drugs are being tested in NCT03687710?

Interventions in NCT03687710: Multidomain precision medicine intervention.

What condition does NCT03687710 study?

NCT03687710 studies Alzheimer Disease, Mild Cognitive Impairment.

Is NCT03687710 still recruiting?

NCT03687710 is currently enrolling by invitation. Last updated 30 March 2026.

Last reviewed 2026-03-30 · How we verify

NCT03687710: CEDAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Comparative Effectiveness Dementia & Alzheimer's Registry

ENROLLING BY INVITATION Last updated 30 March 2026

What this trial tests

trial testing Multidomain precision medicine intervention in Alzheimer Disease in 452 participants. Enrolling by invitation.

Timeline

16 February 2015

Primary endpoint
30 June 2028

30 June 2028

Quick facts

Lead sponsor	Weill Medical College of Cornell University
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	452
Start date	16 February 2015
Primary completion	30 June 2028
Estimated completion	30 June 2028
Sites	1 location across United States

Drugs / interventions tested

Multidomain precision medicine intervention

Conditions studied

Alzheimer Disease — all drugs for Alzheimer Disease →
Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Weill Medical College of Cornell University

Who can join

Adults 18 to 99, any sex, with Alzheimer Disease or Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effectiveness of using clinical precision medicine to develop lifecourse interventions for Alzheimer's disease (AD) prevention and treatment. Anthropometrics, blood biomarkers (including genetics), and cognition will measured longitudinally to assess the comparative effectiveness of clinical care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
Isaacson RS, Ganzer CA, Hristov H, Hackett K, et al · · 2018 · cited 79× · PMID 30446421 · DOI 10.1016/j.jalz.2018.08.004

Verify or expand the search:

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Other Weill Medical College of Cornell University trials

Trials by the same sponsor.

NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2 · NA · not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 · NA · not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression · NA · not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3 · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03687710 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 30 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03687710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing